Cytotoxic T lymphocytes against HIV
Susceptibility to AIDS progression appears early in HIV infection
Simian immunodeficiency virus-specific T-cell-mediated proliferative response of infected rhesus macaques
Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction
Serum beta2-microglobulin level increases in HIV infection
Serological responses of cats to feline immunodeficiency virus
Macrophage-HIV interaction
Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal
Opportunistic infections and malignancies in 231 Danish AIDS patients
Cerebrovascular disease in AIDS
Male knowledge of and attitudes and practices towards AIDS in Zimbabwe
Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583–599), do not correlate significantly with outcome in HIV infection
Zidovudine inhibits functional extracellular monocytic interleukin-1
Direct visualization of Mycobacterium tuberculosis in a blood sample from an AIDS patient
Risk factors for HIV-1 infection in parenteral drug uses
Malignant melanoma and Kaposi's sarcoma
Infection of human epidermal Langerhans' cells by HIV
Infection of human epidermal Langerhans' cells by HIV [reply],
Report of a WHO workshop on the measurement and significance of neutralizing antibody to HIV and SIV, London, 3–5 October 1988
Statistics from the World Health Organization and the Centers for Disease Control
Bibliography of the current world literature